Article Text

Download PDFPDF
Cerebral palsy in under 25 s: assessment and management (NICE Guideline NG62)
  1. Meera Shaunak,
  2. Veronica B Kelly
  1. Mary Sheridan Centre for Child Health, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
  1. Correspondence to Dr Meera Shaunak, Mary Sheridan Centre for Child Health, Guy’s and St Thomas’ NHS Foundation Trust, London SE11 4TH, UK; meera.shaunak{at}nhs.net

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Cerebral palsy is the most common cause of physical disability in children and young people in high-income  countries, with a prevalence of 2.0–2.5 cases per 1000 live births.1 The physical manifestations of disability vary depending on the location and extent of underlying brain damage and may change over time. There is no cure for cerebral palsy. Management focuses on optimising functional ability, decreasing secondary musculoskeletal deformity and managing comorbidities.

The current guideline

In January 2017, the National Institute for Health and Care Excellence (NICE) published  guidance entitled, ‘Cerebral palsy in under 25 s: assessment and management’1 (box 1). The guideline aims to standardise the assessment and management of developmental and clinical comorbidities associated with cerebral palsy, from birth up to the age of 25 years. It is intended to be used in conjunction with, ‘Spasticity in under 19 s: management’, a NICE guideline published in 2012, which provides recommendations for optimising movement and posture in cerebral palsy.2 Here, we summarise the new guidance for healthcare professionals and discuss its relevance to clinical practice.

Box 1

Resources

  • Cerebral palsy in under 25 s: assessment and management (2017) National Institute for Health and Care Excellence (NICE) guideline (NG62)

  • Spasticity in under 19 s: management (2012) NICE guideline (CG145)

  • Constipation in children and young people: diagnosis and management (2010) NICE guideline (CG99)

  • Gastro-oesophageal reflux disease in children and young people: diagnosis and management (2015) NICE guideline (NG1)

  • Urinary incontinence in neurological disease: assessment and management (2012) NICE guideline (CG148)

  • Epilepsy in children and young people (2013) NICE quality standard (QS27)

  • Depression in children and young people: identification and management (2005) NICE guideline (CG28)

  • Learning disabilities: identifying and managing mental health problems (2017) NICE quality standard (QS142)

  • Transition from children’s to adults’ services for young people using health or social care services (2016) NICE guideline (NG43)

Key recommendations

Diagnosing cerebral palsy

  • Identify independent risk …

View Full Text

Footnotes

  • Contributors MS designed and wrote the review article. VK critically appraised drafts, contributed expertise and approved the final copy for submission.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.